-2%
Zepatid is prescribed alongside proper diet and physical activity to enhance blood sugar control in adults with type 2 diabetes.
- Not recommended for individuals with a history of pancreatitis.
- Not approved for treating type 1 diabetes.
- Always take medication following the advice of a registered physician.
Tirzepatide acts on both GIP and GLP-1 receptors. It is a synthetic 39-amino-acid peptide with a C20 fatty diacid chain, which helps it bind to albumin and extend its half-life. By activating these receptors, tirzepatide increases insulin release and reduces glucagon levels, both of which depend on glucose levels.